Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye

NCT02815293 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: AGN-195263
DRUG: Vehicle

Sponsor

Allergan